Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.

Summary

The STEMFOOT Pilot Study is a single center randomized open phase I clinical intervention pilot trial with the aim of investigating the treatment effect of an allogenic adipose-derived mesenchymal stromal cell product (C2C\_ASC) compared to conventional optimal treatment on healing and complications of foot ulcers in diabetes patients.

Timeline

Start

2022-12-15

Primary completion

2025-11-28

Completion

2025-11-28

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulties in enrolling trial subjects within in- and exclusion criteria, despite the trial period having been extended several times.”

Drugs

Indications